Research & Development



  “哈哈哈……”阿嬌似乎發現了什麼好玩的事情大笑了起來。   馭者大笑道︰“正是,僕下也久慕雲氏美食,听說有一種叫做蛋糕的美食,已經風靡長安,長上不可不嘗。”258彩票网   主父偃大叫道︰“今日不听我言,他日你我定會死無葬身之地。”3.6亿彩票巨奖   準備幫丈夫跟甦稚求婚的張氏,似乎忘記了自己的使命,正和廚娘在一起,還用厚厚的麻布手套將一個個烤盤從烤爐里取出來,烤盤上全是撒了很多芝麻的麻餅。   相比宋喬,雲瑯發現自己什麼都沒有……他不想讓宋喬失望,就回到屋子里,翻騰了好久,才找到當初太宰要的祭祀用的玉器。2092期福利彩票

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo